According to Lithuanian media outlet lrytas.lt, on June 29th, a proposed amendment to the "Tobacco, Tobacco Products, and Related Products Control Law" by the Lithuanian government garnered support from 63 members of parliament, with 2 opposing and 5 abstaining. The amendment is currently awaiting final confirmation.
The amendment aims to prohibit the flavoring of e-cigarette products, with plans for it to take effect on May 1st next year.
Member of Parliament Ieva Kačinskaitė-Urbonienė disagrees with the proposed amendment, stating that it is an inappropriate measure that will not effectively address child health issues.
Another legislator, Aurelijus Veryga, holds a contrasting view. He believes that manufacturers are well aware that flavor additives in e-cigarettes attract consumers, and that banning such additives is both logical and in line with EU laws.
MP Vytautas Bacas expressed dissatisfaction with the effective date of the amendment, arguing that it should be brought forward to November 1 of this year.
Antanas Matulas, the chairman of the Parliamentary Health Affairs Committee, urges the public not to doubt any ill intentions behind the proposed amendment and affirms that it is also likely to take effect ahead of schedule.
References:
【1】The Seimas is inclined to ban electronic cigarettes containing sugar and sweeteners.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
